Associate Professor, Division of Infectious Diseases
BIOGRAPHY
Speaker
Event Date & Time
DATE: September 24th, 2020
TIME: 10:00am PT
Abstract
Assessing the risk of bacterial infection in patients with lower respiratory tract infections (LRTI) and sepsis can be challenging as clinicians often have to rely on clinical observation and educated guesswork in the absence of definitive microbial diagnostics. When bacterial respiratory infections or sepsis are suspected, early intervention with appropriate antibiotic therapy is crucial to outcomes. In this webinar you will learn about how to use Procalcitonin (PCT) to assess the risk of bacterial infection and to aid in antibiotic stewardship when assessing these patients. Join Trevor Van Schooneveld, MD, FACP as he discusses the regulation and kinetics of PCT during infection and the evidence of PCT as a valuable tool in assessing patients in the current COVID-19 epidemic. You will also learn about using PCT to aid in antibiotic stewardship and implementation best practices.
Learning Objectives:
- Review biochemistry and kinetics of PCT in primary and secondary bacterial infection
- Analyze PCT as a biomarker to help assess and manage bacterial infection in the current viral pandemic
- Differentiate the data supporting PCT-aided antibiotic stewardship in LRTI and sepsis
- Explore best practices for a successful PCT implementation and confident clinical adoption of optimally valuable clinical application.
Webinars will be available for unlimited on-demand viewing after live event.
LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.
You May Also Like
DEC 10, 2024 | 9:00 AM
To-date, proteomic analysis has been severely limited in scale and resolution. Analyzing protein samples using an intact, single-molecule approach holds th...
OCT 02, 2024 | 7:30 AM
De novo gene synthesis and protein expression are established technologies that can give access to nearly any target DNA or protein sequence, allowing for engineering of biologics. In this p...
Loading Comments...